Sarepta Therapeutics (SRPT) Change in Inventory (2016 - 2026)

Sarepta Therapeutics' Change in Inventory history runs 11 years deep, the most recent figure standing at $69.8 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 60.67% year-over-year to $69.8 million; the TTM figure through Mar 2026 stood at $193.5 million (down 62.21% YoY), while the FY2025 annual figure was $301.1 million, down 23.81% from the prior year.
• Change in Inventory for Q1 2026 stood at $69.8 million, up from -$18.5 million in the prior quarter.
• The five-year high for Change in Inventory was $177.4 million in Q1 2025, with the low at -$18.5 million in Q4 2025.
• The 5-year median for Change in Inventory is $59.2 million (2025), against an average of $56.7 million.
• The sharpest annual moves came in 2024 and 2025: Change in Inventory surged 19675.16% in 2024, then tumbled 111.43% in 2025.
• Sarepta Therapeutics' Change in Inventory stood at $8.9 million in 2022, then surged by 959.73% to $94.1 million in 2023, then soared by 71.79% to $161.7 million in 2024, then sank by 111.43% to -$18.5 million in 2025, then jumped by 477.57% to $69.8 million in 2026.
• Business Quant data shows SRPT's Change in Inventory at $69.8 million in Q1 2026, -$18.5 million in Q4 2025, and $83.0 million in Q3 2025.